Journal article icon

Journal article

Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity

Abstract:
Identification of alterations in the cellular composition of the human immune system is key to understanding the autoimmune process. Recently, a subset of FOXP3+ cells with low CD25 expression was found to be increased in peripheral blood from systemic lupus erythematosus (SLE) patients, although its functional significance remains controversial. Here we find in comparisons with healthy donors that the frequency of FOXP3+ cells within CD127lowCD25low CD4+ T cells (here defined as CD25lowFOXP3+ T cells) is increased in patients affected by autoimmune disease of varying severity, from combined immunodeficiency with active autoimmunity, SLE to type 1 diabetes. We show that CD25lowFOXP3+ T cells share phenotypic features resembling conventional CD127lowCD25highFOXP3+ Tregs, including demethylation of the Treg-specific epigenetic control region in FOXP3, HELIOS expression, and lack of IL-2 production. As compared to conventional Tregs, more CD25lowFOXP3+ HELIOS+ T cells are in cell cycle (33.0% vs 20.7% Ki-67+ ; P = 1.3 x 10-9 ) and express the late-stage inhibitory receptor PD-1 (67.2% vs 35.5%; P = 4.0 x 10-18 ), while having reduced expression of the early-stage inhibitory receptor CTLA-4, as well as other Treg markers, such as FOXP3 and CD15s. The number of CD25lowFOXP3+ T cells is highly correlated (P = 3.1 x 10−7 ) with the proportion of CD25highFOXP3+ T cells in cell cycle (Ki-67+ ). These findings suggest that CD25lowFOXP3+ T cells represent a subset of Tregs that are derived from CD25highFOXP3+ T cells, and are a peripheral marker of recent Treg expansion in response to an autoimmune reaction in tissues.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.jaut.2017.07.009

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Human Genetics Wt Centre
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Role:
Author


More from this funder
Funding agency for:
Ferreira, R
Grant:
Post-doctoral fellowship (2-APF-2017-420-A-N
More from this funder
Grant:
Cambridge Biomedical Research Centre
More from this funder
Grant:
Diabetes
InflammationLaboratoryfromthe 549JDRF(9-2011-253


Publisher:
Elsevier
Journal:
Journal of Autoimmunity More from this journal
Volume:
84
Pages:
75-86
Publication date:
2017-07-23
Acceptance date:
2017-07-13
DOI:
ISSN:
0896-8411


Keywords:
Pubs id:
pubs:708914
UUID:
uuid:19018978-276a-42ae-8be9-ae35476f0794
Local pid:
pubs:708914
Deposit date:
2017-07-21

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP